Cantabio Pharmaceuticals Competitors and Similar CompaniesClear all

Novartis's competitors and similar companies include Hutchison China Meditech, Quantum Hi-Tech (China) Biological and Pfizer.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Hutchison China Meditech
Hutchison China Meditech
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
Quantum Hi-Tech (China) Biological
Quantum Hi-Tech (China) Biological
Quantum Hi-Tech (China) Biological is a biotechnology company.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date
Founding Date
1996
Founding Date
2000
Founding Date
2000
Founding Date
1849
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
Shanghai, CN HQ
Beijing, CN
Jiangsu, CN
Shanghai, CN
Shanghai, CN
Hong Kong, HK
Hong Kong, HK
see more
Locations
Guang Zhou Shi, CN HQ
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Footscray, AU
Mulgrave, AU
Sydney, AU
Wien, AT
see more
Employees
Employees
75,883
Employees
1,811
Employees
1,814
Employees
81,0008% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.6 b
Valuation ($)
N/A
Valuation ($)
163.9 b

Financial

Revenue (est.)
Revenue (est.)
$56.7b (FY, 2025)
Revenue (est.)
$548.5m (FY, 2025)
Revenue (est.)
¥1.1b (FY, 2025)
Revenue (est.)
$62.6b (FY, 2025)
Cost of goods
Cost of goods
$8.4b (FY, 2025)
Cost of goods
$324.4m (FY, 2025)
Cost of goods
¥810m (FY, 2025)
Cost of goods
$16.1b (FY, 2025)
Gross profit
Gross profit
$49.8b (FY, 2025)
Gross profit
$224.2m (FY, 2025)
Gross profit
¥320.9m (FY, 2025)
Gross profit
$46.5b (FY, 2025)
Net income
Net income
$14b (FY, 2025)
Net income
$435.1m (FY, 2025)
Net income
¥13.6m (FY, 2025)
Net income
$7.8b (FY, 2025)

Operating

Phase III Trials Products
Phase III Trials Products
44 (FY, 2022)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
32 (FY, 2024)
Registration Phase Products
Registration Phase Products
8 (FY, 2022)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
5 (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 6.5m
Total funding raised
$ 100m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Hutchison China Meditech
HQ
Shanghai, CN
Employees
1,811

Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.

View company
Quantum Hi-Tech (China) Biological
HQ
Guang Zhou Shi, CN
Employees
1,814

Quantum Hi-Tech (China) Biological is a biotechnology company.

View company
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company